Gulf Evaluation of VAlproate (Depakine Chrono) in maNia Study

NCT00477373 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Bipolar Disorder

Interventions

DRUG: depakine chrono

Sponsor

Sanofi